申请人:Pfizer Products Inc.
公开号:EP1033366A2
公开(公告)日:2000-09-06
The compound
is a neuropeptide Y antagonist and is effective in treating feeding disorders, cardiovascular diseases and other physiological disorders.
该化合物
是一种神经肽 Y 拮抗剂,可有效治疗进食障碍、心血管疾病和其他生理紊乱。